00968nas a2200181   4500000000100000008004100001260001200042100001200054700001300066700001300079700001200092245011600104856009900220300001300319490000700332520043300339022001400772       2020                            d  c06/20201 aKumar B1 aThakur V1 aNarang T1 aDogra S00aResponse to "Three drugs are unnecessary for treating paucibacillary leprosy-A critique of the WHO guidelines".  uhttps://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0008169&type=printable  ae00081690 v143 aWe read with interest the viewpoint by Lockwood and colleagues on the recent World Health Organization (WHO) guidelines recommending three drugs for treating paucibacillary (PB) leprosy. Out of the various other issues raised by the authors (namely, diagnostic tests, reactions, stigma, and disability), we would like to submit our perception only on the issue of addition of clofazimine to this recommended therapeutic regimen.  a1935-2735